High cholesterol and life insurance

A smaller factor than people expect

Cholesterol is one of the numbers people worry about most before they apply. It is also one that moves the outcome least on its own.

Take a typical applicant with a moderately raised profile, no history of heart or blood vessel disease, and nothing else notable. Standard rates are the usual result. Preferred classes may be out of reach, since they require unusually good numbers. But that is a difference between two good outcomes, not between a good one and a bad one.

The ratio, not the total

This is the part worth understanding. It explains results that otherwise look odd.

Underwriters generally look at the relationship between total cholesterol and HDL cholesterol, rather than at total cholesterol by itself. HDL is the part linked with lower heart risk. So a high total with a high HDL is a different picture from the same total with a low HDL.

The practical effect is that two applicants with the same total cholesterol can be assessed differently. Someone with a total figure that sounds alarming can be viewed favourably if the mix is good.

This is also why a single number quoted from memory is not much use on an application. The full lipid panel, the blood test that lists each type of cholesterol, is what gets assessed. It will be in the bloodwork from a paramedical anyway.

Treatment

Being on a statin or another cholesterol-lowering medication is not a negative.

An underwriter would rather see raised cholesterol found, treated and brought under control than left untreated. What they assess is the current profile and how stable it is. A treated profile that has been steady for years is a straightforward file.

Two things do attract attention. One is a profile that stays well outside guidelines despite treatment, which suggests the condition is more resistant. The other is a very recent change in medication. The picture has not settled, and an underwriter may want a more recent result.

Stopping medication before applying is not something to do. That is a medical decision that belongs with your doctor. Beyond that, your prescription history makes the medication visible. A lipid panel showing an untreated profile, next to a record of prescriptions, is a worse combination than either alone.

Familial hypercholesterolemia

This is genuinely different. It is the reason this page exists separately from a general heart page.

Familial hypercholesterolemia is an inherited condition. It produces very high cholesterol from early life. Because the exposure begins in childhood rather than in middle age, the effect built up over a lifetime is greater. Underwriters treat it more seriously than acquired raised cholesterol at the same measured level.

Four things matter in the assessment. How well it has been controlled on treatment. How long it has been managed. Whether there is any sign of heart or blood vessel disease already. And what the family history shows about early events in close relatives.

Offers are made. A rating is more likely than with ordinary raised cholesterol. Insurers also differ noticeably here, which is a reason not to rely on a single application.

Family history in general is covered in how family medical history is used. The age at which relatives were affected matters there for the same reason it matters here.

Where it starts to count

It counts in combination, and where there is already disease.

Raised cholesterol alongside high blood pressure, a build above guidelines and raised glucose is read as a cluster. The assessment reflects the whole pattern rather than four separate entries. The related pages are high blood pressure, height, weight and life insurance and Type 2 diabetes.

Where there is an existing heart or blood vessel diagnosis, the cholesterol becomes a secondary detail within that larger assessment. See coronary artery disease.

Cholesterol alongside nicotine use is a combination that carries more weight than the sum of the two. The same is true clinically.

Applying

Disclose it and disclose the medication. Have your most recent lipid panel to hand if you can. It saves a round of questions.

If bloodwork at the paramedical returns a result that surprises you, ask what the insurer plans to do with it. Sometimes a single result sits out of line with your own doctor’s records. Sending in those records is a reasonable request and is often accepted.

Anything you want to do about the result itself belongs with your doctor. The reason to have that conversation is your own health, not an insurance file.